GENE ONLINE|News &
Opinion
Blog

Daniel Ojeda

WRITTEN BY Daniel Ojeda

Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
Amgen Acquires Teneobio to Snag New Class of Antibody Therapies
2021-07-31
Aridis Pharmaceuticals’ Antibody Shows Early Promise in the Fight Against COVID-19
2021-07-28
AI in Healthcare: Current Uses and The Need of the Hour to Accelerate Adoption
2021-07-27
Albireo Gets Back-to-Back Approvals for Rare Liver Disease Drug
2021-07-26
Merck’s FDA approval for Pneumonia Vaccine Sets Up Collision Course with Pfizer
2021-07-20
Aftermath of Biogen’s Alzheimer’s Drug Approval Continues as Some Hospitals, Insurers Refuse Administration
2021-07-18
Eli Lilly Infuses $1 Billion into Protomer Acquisition to Procure “Next-Gen” Insulin Products
2021-07-15
COVID-19: FDA Adds New Warning For a Rare Autoimmune Disorder to J&J’s Vaccine
2021-07-14
Philip Morris International Makes Second Acquisition in a Week to Push its “Beyond Nicotine” Strategy
2021-07-11
Moderna Looks Beyond COVID as it Doses First Patient With mRNA-Based Seasonal Flu Vaccine
2021-07-09
FDA Rejection of Type 1 Diabetes Drug Impacts Provention Bio’s Stocks
2021-07-07
EQT Private Equity and Goldman Sachs Spend $8.5 Billion to Acquire Parexel
2021-07-04
AbbVie’s JAK1 Inhibitor Aces Ulcerative Colitis Trial, Prospers Amid Tough Regulatory Climate
2021-07-02
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
1 2 3 4 5 … 9
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top